XML 44 R34.htm IDEA: XBRL DOCUMENT v3.25.1
Note 2 - Significant Accounting Policies (Details Textual)
 3 Months Ended
Apr. 22, 2024
USD ($)
$ / shares
shares
Mar. 31, 2025
USD ($)
shares
Mar. 31, 2024
USD ($)
Dec. 31, 2024
USD ($)
Sep. 30, 2024
USD ($)
Dec. 31, 2023
USD ($)
Amortization of above and below Market Leases   $ 1,022 $ 1,244      
Deferred Costs   1,400,000   $ 1,700,000    
Operating Lease, Initial Direct Cost Expense, over Term   134,776 124,822      
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation   11,956,853   8,036,496    
Restricted Cash   4,000,000   5,000,000    
Cash, Uninsured Amount   5,300,000   1,000,000    
Deferred Offering Costs   60,000   0    
Impairment of Real Estate   26,943 100,000      
Proceeds from Sale of Real Estate   2,800,000        
Gain (Loss) on Sale of Properties   200,000        
Liabilities, Fair Value Disclosure   0   0    
Equity Securities, FV-NI   29,519   206,177    
Accounts Payable and Accrued Liabilities   3,794,229   3,290,170    
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition   229,502 341,921      
Operating Lease, Lease Income   4,032,429 4,639,726      
Payments of Debt Issuance Costs   61,914 18,131      
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation   (118,905) (866,768)      
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation   $ (9,513,802) (7,652,790)      
Revision of Prior Period, Error Correction, Adjustment [Member]            
Accounts Payable and Accrued Liabilities           $ (21,189)
Additional Paid in Capital           $ 21,189
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition     317,077      
Operating Lease, Lease Income     220,620      
Previously Reported [Member]            
Payments of Debt Issuance Costs     18,131      
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation     (265,491)      
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation     (247,360)      
Revision of Prior Period, Adjustment [Member]            
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation     $ 18,131      
Conduit Pharmaceuticals Inc [Member] | Private Warrants [Member]            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares 540,000 540,000        
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares $ 3.12          
Warrants and Rights Outstanding, Term (Year) 2 years          
Warrant or Right, Exercisable Period (Year) 1 year          
Warrants and Rights Outstanding $ 891,000 $ 29,519     $ 0  
Conduit Pharmaceuticals Inc [Member]            
Lock-up Agreement, Shares (in shares) | shares 2,700,000          
Investment Owned, Balance, Shares (in shares) | shares 4,015,250          
Equity Securities, FV-NI   $ 29,519   200,000    
Fair Value, Inputs, Level 1 [Member]            
Marketable Securities       $ 0    
Discontinued Operations, Disposed of by Sale [Member]            
Number of Real Estate Properties   6 27      
Gain (Loss) on Sale of Properties   $ 200,000 $ 2,000,000      
Building and Tenant Improvements [Member]            
Accounts Payable     247,360      
Maximum [Member] | Furniture and Fixtures [Member]            
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Life Used for Depreciation (Year)   5 years        
Minimum [Member]            
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Life Used for Depreciation (Year)   1 year        
Minimum [Member] | Leasehold Improvements [Member]            
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Life Used for Depreciation (Year)   1 year        
Lease Intangibles [Member] | Maximum [Member]            
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Life Used for Depreciation (Year)   10 years        
Finite-lived Intangibles, Other Than Lease Intangibles [Member]            
Amortization of Intangible Assets   $ 4,382 $ 4,382